Dr. Pankaj Kumar Pande (Colo-Rectal Surgeon)

About Dr. Pankaj Kumar Pande

• Dr Pankaj Kumar Pande is a well-known name in the field of Surgical Oncology with 30+ experience.
• He has operated successfully numerous surgeries (open and Laparoscopic)mainly gastrointestinal, Colo-Rectal, HIPEC, and Thoracic, Gynaecology, Breast, Head and Neck, bone and soft tissue.
• Organized various health awareness camps in cities and towns of India. 
• Did his fellowship from Samsung Medical Center, Seoul, Korea on Laparoscopic and open colorectal surgery.
• Well trained in robotic and laparoscopic colorectal surgery at Cook County Hospital and Lutheran General Hospital, Chicago, USA.
• Efficiently handles Gastrointestinal cancer surgery and colorectal surgery, Cytoreductive surgery and HIPEC in Peritoneal Surface Malignancies (Pseudomyxoma Peritonei, Colorectal, Mesothelioma, Ovarian, and primary peritoneal cancer.
• His expertise lies in oncologic surgeries including (hepatobiliary, gynecological, thoracic, breast, and head and neck surgeries).
• Got GEM award from Max Healthcare for outstanding and exemplary performance in the field of medical excellence
• Received Chikitsa Bhushan Award for excellence in surgery by Indian Medical Association.

Special Interest

Gastrointestinal cancer surgery Colorectal Surgery Cytoreductive surgery Hepatobiliary Surgery Neck Surgeries Endosurgery Gastroscopy Piles Treatment (Non Surgical) Liver Disease Treatment Trauma Surgery Thyroid Surgery Colonoscopy Diabetic Foot Treatment/Surgery Endoscopic Surgery Sclerotherapy.

Work Profile

Consultant, MAX Hospital.

Consultant, BLK Cancer Centre at BLK Super Speciality Hospital, New Delhi.

Education

• MS, 1993, University of Delhi.

• MBBS, 1987, University of Delhi.

Awards

Got GEM award from Max Healthcare for outstanding and exemplary performance in the field of medical excellence Received Chikitsa Bhushan Award for excellence in surgery by Indian Medical Association.

Paper Published

• Multiple Gastrointestinal Cancers in a Single Patient- A Rare Clinical Entity.
• Management of Borderline Ovarian Tumors- Still a Gray Zone.
• Reconstruction in Breast Conservation therapy- Single tertiary care Institute experience with 472 patients.
• Resection after Neoadjuvant Chemotherapy in Advanced Carcinoma of the Gall Bladder: A Retrospective Study.
• K-Ras Gene Mutation and RASSFIA, FHIT, and MGMT Gene Promoter Hypermethylation: Indicators of Tumor Staging and Metastasis in Adenocarcinomatous Sporadic Colorectal Cancer in Indian Population.
• Neoadjuvant Chemoradiotherapy and Rectal cancer: Can India follow the West.